Published in Cardiol Res Pract on June 12, 2012
Role of Chemoreceptor Activation in Hemodynamic Responses to Electrical Stimulation of the Carotid Sinus in Conscious Rats. Hypertension (2015) 0.80
Effects of low-level carotid baroreflex stimulation on atrial electrophysiology. J Interv Card Electrophysiol (2015) 0.77
Depolarization of sensory terminals and the initiation of impulses in the muscle spindle. J Physiol (1950) 16.04
The sympathetic control of blood pressure. Nat Rev Neurosci (2006) 6.44
Blood pressure control--special role of the kidneys and body fluids. Science (1991) 4.48
Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial. J Am Coll Cardiol (2011) 3.08
Systemic arterial baroreceptor reflexes. Physiol Rev (1976) 2.64
Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients. Hypertension (2010) 2.38
Baroreceptors and the long-term control of blood pressure. Exp Physiol (2004) 2.26
Baroceptor function in chronic renal hypertension. Circ Res (1956) 2.12
The ion channel ASIC2 is required for baroreceptor and autonomic control of the circulation. Neuron (2009) 1.97
Role of baroreceptor reflex in daily control of arterial blood pressure and other variables in dogs. Circ Res (1973) 1.95
Prolonged activation of the baroreflex produces sustained hypotension. Hypertension (2004) 1.86
Novel baroreflex activation therapy in resistant hypertension: results of a European multi-center feasibility study. J Am Coll Cardiol (2010) 1.82
Effects of chronic baroreceptor stimulation on the autonomic cardiovascular regulation in patients with drug-resistant arterial hypertension. Hypertension (2009) 1.33
Receptors under pressure. An update on baroreceptors. Circ Res (1980) 1.31
The arterial baroreflex: functional organization and involvement in neurologic disease. Neurology (2008) 1.29
Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: results from the Barostim neo trial. J Am Soc Hypertens (2012) 1.20
Baroreflex activation therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial. J Am Soc Hypertens (2012) 1.19
Baroreceptors, baroreceptor unloading, and the long-term control of blood pressure. Am J Physiol Regul Integr Comp Physiol (2005) 1.07
Carotid baroreceptor stimulation as a therapeutic target in hypertension and other cardiovascular conditions. Expert Opin Ther Targets (2009) 1.05
An implantable carotid sinus baroreflex activating system: surgical technique and short-term outcome from a multi-center feasibility trial for the treatment of resistant hypertension. Eur J Vasc Endovasc Surg (2007) 1.02
Mechanisms of resetting of arterial baroreceptors: an overview. Am J Med Sci (1988) 0.96
Baroreceptor resetting and other determinants of baroreflex properties in hypertension. Clin Exp Pharmacol Physiol Suppl (1989) 0.96
Mechanisms determining sensitivity of baroreceptor afferents in health and disease. Ann N Y Acad Sci (2001) 0.96
Arterial baroreceptor resetting in hypertension (the J. W. McCubbin memorial lecture). Clin Exp Pharmacol Physiol Suppl (1989) 0.92
Summation of bilateral carotid sinus signals in the barostatic reflex. Am J Physiol (1965) 0.91
Improved cardiac structure and function with chronic treatment using an implantable device in resistant hypertension: results from European and United States trials of the Rheos system. J Am Coll Cardiol (2011) 0.90
Effects of unilateral and bilateral carotid baroreflex stimulation on cardiac and neural sympathetic discharge oscillatory patterns. Circulation (2003) 0.88
Functional asymmetry in carotid sinus cardiac reflexes in humans. Eur J Appl Physiol Occup Physiol (1990) 0.87
Chronic baroreflex activation: a potential therapeutic approach to heart failure with preserved ejection fraction. J Card Fail (2010) 0.85
Unilateral carotid sinus stimulation and muscle sympathetic nerve activity in man. Med Sci Sports Exerc (1996) 0.83
Acute device-based blood pressure reduction: electrical activation of the carotid baroreflex in patients undergoing elective carotid surgery. Vascular (2007) 0.82
The importance of the autonomic nervous system in health and disease. Aust N Z J Med (1997) 0.82
Carotid baroreflex activation: past, present, and future. Curr Hypertens Rep (2010) 0.81
Rheos Baroreflex Hypertension Therapy System to treat resistant hypertension. Expert Rev Med Devices (2008) 0.81
Unilateral carotid-cardiac baroreflex responses in humans. Am J Physiol (1993) 0.80
Carotid baroreceptor stimulation for the treatment of resistant hypertension. Int J Hypertens (2011) 0.79
Complications of carotid-sinus stimulation. N Engl J Med (1969) 0.77
Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med (2003) 4.59
Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Ann Intern Med (2009) 4.20
Sharing Clinical Trial Data: A Proposal From the International Committee of Medical Journal Editors. Ann Intern Med (2016) 3.95
Accuracy of computed tomographic angiography and magnetic resonance angiography for diagnosing renal artery stenosis. Ann Intern Med (2004) 3.38
Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial. J Am Coll Cardiol (2011) 3.08
Sharing Clinical Trial Data--A Proposal from the International Committee of Medical Journal Editors. N Engl J Med (2016) 3.06
Cerebral hyperperfusion syndrome. Lancet Neurol (2005) 3.01
Uniform format for disclosure of competing interests in ICMJE journals. N Engl J Med (2009) 2.46
Home blood pressure measurement: a systematic review. J Am Coll Cardiol (2005) 2.36
Self-measurement of blood pressure at home reduces the need for antihypertensive drugs: a randomized, controlled trial. Hypertension (2007) 2.33
Sharing clinical trial data: a proposal from the International Committee of Medical Journal Editors. Lancet (2016) 2.25
Interaction between the Gly460Trp alpha-adducin gene variant and diuretics on the risk of myocardial infarction. J Hypertens (2009) 2.14
The Framingham prediction rule is not valid in a European population of treated hypertensive patients. J Hypertens (2002) 2.03
Treatment of atherosclerotic renal artery stenosis: time for a new approach. JAMA (2013) 2.00
Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial. J Hypertens (2004) 1.87
Renal clearance of B-type natriuretic peptide and amino terminal pro-B-type natriuretic peptide a mechanistic study in hypertensive subjects. J Am Coll Cardiol (2009) 1.87
Novel baroreflex activation therapy in resistant hypertension: results of a European multi-center feasibility study. J Am Coll Cardiol (2010) 1.82
Increased aortic pulse wave velocity is associated with silent cerebral small-vessel disease in hypertensive patients. Hypertension (2008) 1.76
On-treatment diastolic blood pressure and prognosis in systolic hypertension. Arch Intern Med (2007) 1.75
Systolic blood pressure variability as a risk factor for stroke and cardiovascular mortality in the elderly hypertensive population. J Hypertens (2003) 1.74
Is there a side predilection for cerebrovascular disease? Hypertension (2003) 1.71
Electronic monitoring of adherence as a tool to improve blood pressure control. A randomized controlled trial. Am J Hypertens (2007) 1.66
Patients using vitamin K antagonists show increased levels of coronary calcification: an observational study in low-risk atrial fibrillation patients. Eur Heart J (2011) 1.60
Protein supplementation lowers blood pressure in overweight adults: effect of dietary proteins on blood pressure (PROPRES), a randomized trial. Am J Clin Nutr (2012) 1.59
Different classifications of nocturnal blood pressure dipping affect the prevalence of dippers and nondippers and the relation with target-organ damage. J Hypertens (2008) 1.57
Assessing medication adherence simultaneously by electronic monitoring and pill count in patients with mild-to-moderate hypertension. Am J Hypertens (2009) 1.55
Brain microbleeds are associated with ambulatory blood pressure levels in a hypertensive population. Hypertension (2007) 1.55
Toward more uniform conflict disclosures--the updated ICMJE conflict of interest reporting form. N Engl J Med (2010) 1.52
Polymorphisms in human connexin40 gene promoter are associated with increased risk of hypertension in men. J Hypertens (2006) 1.52
Alpha-adducin Gly460Trp polymorphism and renal hemodynamics in essential hypertension. Hypertension (2004) 1.51
Prevalence and persistence of masked hypertension in treated hypertensive patients. Am J Hypertens (2007) 1.50
Variation in Renin-Angiotensin system and salt-sensitivity genes and the risk of diabetes mellitus associated with the use of thiazide diuretics. Am J Hypertens (2009) 1.50
Prevalence of the white-coat effect at multiple visits before and during treatment. J Hypertens (2006) 1.48
Configuration of the microcirculation in pre-eclampsia: possible role of the venular system. J Hypertens (2007) 1.48
Genetic contribution to the acute effects of angiotensin II type 1 receptor blockade. J Hypertens (2005) 1.45
Sharing clinical trial data. BMJ (2016) 1.43
Renal artery stenosis: cost-effectiveness of diagnosis and treatment. Radiology (2007) 1.43
Sustained acute voltage-dependent blood pressure decrease with prolonged carotid baroreflex activation in therapy-resistant hypertension. J Hypertens (2012) 1.43
Erythrocytapheresis versus phlebotomy in the initial treatment of HFE hemochromatosis patients: results from a randomized trial. Transfusion (2011) 1.43
Blood pressure and renal function before and after percutaneous transluminal renal angioplasty in fibromuscular dysplasia: a cohort study. J Hypertens (2013) 1.43
Pressure-dependence of arterial stiffness: potential clinical implications. J Hypertens (2015) 1.42
The Glu298Asp polymorphism of the NOS 3 gene as a determinant of the baseline production of nitric oxide. J Hypertens (2002) 1.42
Predictive value of clinic and ambulatory heart rate for mortality in elderly subjects with systolic hypertension. Arch Intern Med (2002) 1.42
Prevalence, causes, and consequences of masked hypertension: a meta-analysis. Am J Hypertens (2008) 1.39
Chlamydia pneumoniae seropositivity and systemic and renovascular atherosclerotic disease. Arch Intern Med (2002) 1.39
Effects of chronic baroreceptor stimulation on the autonomic cardiovascular regulation in patients with drug-resistant arterial hypertension. Hypertension (2009) 1.33
Uniform format for disclosure of competing interests in ICMJE journals. N Z Med J (2009) 1.33
Vascular inflammation in cerebral small vessel disease. Neurobiol Aging (2011) 1.32
Prognostic significance of electrocardiographic voltages and their serial changes in elderly with systolic hypertension. Hypertension (2004) 1.27
Genetic predisposition to salt-sensitivity: a systematic review. J Hypertens (2004) 1.25
Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: results from the Barostim neo trial. J Am Soc Hypertens (2012) 1.20
Toward more uniform conflict disclosures: the Updated ICMJE conflict of interest reporting form. Croat Med J (2010) 1.19
Uniform format for disclosure of competing interests in ICMJE Journals. Croat Med J (2009) 1.16
Treatment of hypertension in the oldest old: a critical role for frailty? Hypertension (2013) 1.13
Vascular and renal actions of brain natriuretic peptide in man: physiology and pharmacology. Fundam Clin Pharmacol (2005) 1.09
Accumulation of MRI Markers of Cerebral Small Vessel Disease is Associated with Decreased Cognitive Function. A Study in First-Ever Lacunar Stroke and Hypertensive Patients. Front Aging Neurosci (2013) 1.07
The optimal scheme of self blood pressure measurement as determined from ambulatory blood pressure recordings. J Hypertens (2006) 1.04
Chronic coumarin treatment is associated with increased extracoronary arterial calcification in humans. Blood (2010) 1.03
Noninvasive assessment of arterial stiffness should discriminate between systolic and diastolic pressure ranges. Hypertension (2009) 0.99
Ambulatory pulse pressure as predictor of outcome in older patients with systolic hypertension. Am J Hypertens (2002) 0.99
Participation in a clinical trial enhances adherence and persistence to treatment: a retrospective cohort study. Hypertension (2011) 0.98
Associations of ambulatory blood pressure levels with white matter hyperintensity volumes in hypertensive patients. J Hypertens (2009) 0.98
Towards more uniform conflict disclosures: the updated ICMJE conflict of interest reporting form. BMJ (2010) 0.94
Calcium scores and matrix Gla protein levels: association with vitamin K status. Eur J Clin Invest (2010) 0.94
Accuracy of oscillometric blood pressure monitors for the detection of atrial fibrillation: a systematic review. Expert Rev Med Devices (2012) 0.94
Uniform format for disclosure of competing interests in ICMJE journals. CMAJ (2009) 0.93
Masked hypertension, a review of the literature. Blood Press Monit (2007) 0.92
Electronic monitoring of adherence, treatment of hypertension, and blood pressure control. Am J Hypertens (2011) 0.92
Recruitment of participants through community pharmacies for a pharmacogenetic study of antihypertensive drug treatment. Pharm World Sci (2008) 0.91